XM无法为美国居民提供服务。

Reckitt gives weak scrub to valuation stain



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>BREAKINGVIEWS-Reckitt gives weak scrub to valuation stain</title></head><body>

The author is a Reuters Breakingviews columnist. The opinions expressed are her own.

By Karen Kwok

LONDON, July 24 (Reuters Breakingviews) -Reckitt Benckiser RKT.L CEO Kris Licht is giving his firm’s valuation stain a gentle scrub. The 31 billion pound Durex maker is selling some of its home cleaning brands and may exit its baby milk division, which is facing legal woes in the United States. The problem is it’s unclear when Reckitt can sell them, and when investors can leave the infant formula litigation problems behind.

Reckitt has had a rocky year so far. Shareholders have wiped 5 billion pounds off its market value since March, when an Illinois court awarded $60 million in damages to a mother whose child died after consuming Mead Johnson formula milk. The worries are there are more legal hits to come, potentially reaching 2 billion pounds, Bernstein estimates. Inflation is also making it harder for Reckitt to pass on costs to consumers, damaging sales growth. The London-listed group’s shares have fallen 18% so far this year.

As a result Licht is cleaning house. He will sell slow-growing hygiene brands like mould remover Cillit Bang, and is pledging to get out of the nutrition business, which mostly comprises the baby milk maker Mead Johnson. That should highlight the hidden value in Reckitt.

Assume the hygiene castoffs fetch 2.5 times 2023 sales, as per Jefferies estimates, or 4.8 billion pounds. Next, put the rest of the hygiene business on a richer 4.8 times revenue multiple, in line with peers Procter & Gamble PG.N and Church & Dwight CHD.N, and it’s worth 20 billion pounds. Finally, the health unit, which makes Durex condoms, could be valued at 24 billion pounds using a 4 times sales multiple, the average of Haleon HLN.L and Johnson & Johnson JNJ.N. Add it up, and Reckitt might be worth 49 billion pounds including net debt, some 29% above its current enterprise value, even before factoring in the troubled baby milk division.

Yet investors don’t seem convinced. Reckitt shares barely moved on Wednesday morning after the breakup was announced. The lack of clarity on timing is one issue. So far, Licht has not yet given a date for when the baby unit will be sold, raising the risk of higher than expected losses as cases come to trial next year. And the home care assets won’t be sold until the end of next year, and Reckitt hasn’t said whether it will return the money to shareholders or invest in the business. Licht’s fix for Reckitt goes in the right direction, but needs an extra polish.

Follow @karenkkwok on X


CONTEXT NEWS

British consumer goods group Reckitt Benckiser on July 24 said it would sell its home care brands, which include Air Wick and Cillit Bang, and said it was looking at all strategic options for Mead Johnson, which has recently faced litigation in the United States over an infant formula product.

Reckitt acquired U.S. baby formula maker Mead Johnson Nutrition for $16.6 billion in 2017, but is currently seeking to overturn a $60 million verdict in a lawsuit after a jury ordered the unit to pay the mother of a premature baby who died after being fed the Enfamil baby formula.

The British consumer goods company also lowered its full-year sales growth forecast for 2024 to 1%-3%, down from its previous forecast of a 2%-4% rise. Reckitt said it would launch a share buyback of up to 1 billion pounds and increase its interim dividend.

Reckitt shares rose 0.29% at 0907 GMT on July 24.



Editing by Neil Unmack and Oliver Taslic

</body></html>

免责声明: XM Group仅提供在线交易平台的执行服务和访问权限,并允许个人查看和/或使用网站或网站所提供的内容,但无意进行任何更改或扩展,也不会更改或扩展其服务和访问权限。所有访问和使用权限,将受下列条款与条例约束:(i) 条款与条例;(ii) 风险提示;以及(iii) 完整免责声明。请注意,网站所提供的所有讯息,仅限一般资讯用途。此外,XM所有在线交易平台的内容并不构成,也不能被用于任何未经授权的金融市场交易邀约和/或邀请。金融市场交易对于您的投资资本含有重大风险。

所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。

本网站上由XM和第三方供应商所提供的所有内容,包括意见、新闻、研究、分析、价格、其他资讯和第三方网站链接,皆保持不变,并作为一般市场评论所提供,而非投资性建议。所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为适用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。请确保您已阅读并完全理解,XM非独立投资研究提示和风险提示相关资讯,更多详情请点击 这里

风险提示: 您的资金存在风险。杠杆商品并不适合所有客户。请详细阅读我们的风险声明